Edition:
United States

ZIOPHARM Oncology Inc (ZIOP.OQ)

ZIOP.OQ on NASDAQ Stock Exchange Capital Market

4.39USD
23 May 2018
Change (% chg)

$0.00 (+0.00%)
Prev Close
$4.39
Open
$4.38
Day's High
$4.41
Day's Low
$4.35
Volume
66,888
Avg. Vol
321,303
52-wk High
$7.09
52-wk Low
$3.33

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Mar '18 0.15 -0.150
FY 2017 Dec '17 1.60 -0.130
Sep '17 1.60 -0.125
Jun '17 1.60 -0.131
Mar '17 1.60 -0.150
FY 2016 Dec '16 1.60 -0.113
Sep '16 1.60 -0.111
Jun '16 1.70 -1.006
Mar '16 1.97 -0.092
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Jun-18 5 1.19 2.00 0.15 1.11
Quarter Ending Sep-18 5 1.19 2.00 0.15 1.11
Year Ending Dec-18 5 3.49 5.00 0.58 5.81
Year Ending Dec-19 5 5.08 6.40 0.58 90.60
Earnings (per share)
Quarter Ending Jun-18 6 -0.13 -0.10 -0.14 -0.18
Quarter Ending Sep-18 6 -0.13 -0.10 -0.15 -0.19
Year Ending Dec-18 6 -0.53 -0.45 -0.60 -0.65
Year Ending Dec-19 6 -0.45 -0.22 -0.68 -0.31
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 84.06 32.75
P/E High - Last 5 Yrs. -- 293.32 45.73
P/E Low - Last 5 Yrs. -- 91.63 24.23
Beta 1.54 0.90 0.88
Price to Sales (TTM) 139.32 110.95 5.71
Price to Book (MRQ) -- 13.58 5.37
Price to Tangible Book (MRQ) 12.72 14.04 6.94
Price to Cash Flow (TTM) -- 71.44 23.33
% Owned Institutions 54.51 12.71 2.16

Dividends

  Company industry sector
Dividend Yield -- 0.31 1.50
Dividend Yield - 5 Year Avg -- 0.26 1.51
Dividend 5 Year Growth Rate -- 1.66 5.32
Payout Ratio(TTM) -- 15.72 43.29

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -5.89 399.27 9.21
Sales (TTM) vs TTM 1 Yr. Ago -14.29 78.86 5.69
Sales - 5 Yr. Growth Rate 59.39 32.18 10.32
EPS (MRQ) vs Qtr. 1 Yr. Ago 87.01 25.14 19.38
EPS (TTM) vs TTM 1 Yr. Ago 61.51 -- --
EPS - 5 Yr. Growth Rate -- 39.01 10.77
Capital Spending - 5 Yr. Growth Rate -13.77 40.31 15.47

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.81 2.19
Current Ratio (MRQ) 7.83 5.29 2.98
LT Debt to Equity (MRQ) 0.00 22.98 12.17
Total Debt to Equity (MRQ) 0.00 24.63 16.44
Interest Coverage (TTM) -- -99.39 32.81

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 40.04 54.45
Gross Margin - 5 Yr. Avg. -- 51.16 52.21
EBITD Margin (TTM) -762.28 -- --
EBITD - 5 Yr. Avg -3,432.75 -575.09 10.96
Operating Margin (TTM) -767.01 -718.94 4.73
Operating Margin - 5 Yr. Avg. -3,450.43 -596.41 6.40
Pre-Tax Margin (TTM) -789.28 -693.40 5.57
Pre-Tax Margin - 5 Yr. Avg. -3,320.66 -599.76 6.82
Net Profit Margin (TTM) -789.28 -694.62 1.87
Net Profit Margin - 5 Yr. Avg. -3,320.66 -602.62 3.09
Effective Tax Rate (TTM) -- 22.63 23.04
Effective Tax Rate - 5 Yr. Avg. -- 18.22 23.95

Efficiency

  Company industry sector
Revenue/Employee (TTM) 177,472 22,637,573 847,034,055
Net Income/Employee (TTM) -1,400,750 2,973,815 99,640,144
Receivable Turnover (TTM) 216.58 20.17 5.78
Inventory Turnover (TTM) -- 2.37 3.35
Asset Turnover (TTM) 0.05 0.39 0.92

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -39.58 -1.09 10.95
Return on Assets - 5 Yr. Avg. -101.96 -0.58 12.32
Return on Investment (TTM) -45.27 1.57 14.38
Return on Investment - 5 Yr. Avg. -120.26 2.21 16.11
Return on Equity (TTM) -- 2.43 16.07
Return on Equity - 5 Yr. Avg. -220.88 3.09 17.39
  1 Year 3 Year 5 Year
Sales % 58.38 104.69 59.39
EPS (TTM) % -38.10 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for ZIOPHARM Oncology Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 43.01%
# of Holders: 180
Total Shares Held: 61,244,157
3 Mo. Net Change: 516,619
# New Positions: 16
# Closed Positions: 11
# Increased Positions: 62
# Reduced Positions: 58
# Net Buyers: 4
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.